Notably, transcriptomic studies have demonstrated that ACPA-positive individuals and those with arthralgia prior to RA onset exhibit an type I IFN signature—defined as the upregulation of type I IFN-responsive genes—which is significantly associated with increased risk of progression to RA [37,38]. Here, PRTN3 is linked to rheumatoid arthritis.